市場調査レポート

商品コード

1312084

レギュラトリー・アフェアーズ市場：サービス別、適応症別、ステージ別、カテゴリー別、サービスプロバイダー別、企業規模別、エンドユーザー別-2023-2030年の世界予測

Regulatory Affairs Market by Services, Indication, Stage, Category, Service Provider, Company Size, End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

レギュラトリー・アフェアーズの世界市場は、2023年に156億3,000万米ドル、CAGR 10.56%で大幅な成長が予測され、2030年には317億1,000万米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のレギュラトリー・アフェアーズ市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.レギュラトリー・アフェアーズの世界市場規模および予測は？

2.予測期間中、世界のレギュラトリー・アフェアーズ市場を形成するCOVID-19の阻害要因と影響は？

3.レギュラトリー・アフェアーズの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.レギュラトリー・アフェアーズの世界市場における競争戦略は？

5.レギュラトリー・アフェアーズの世界市場における技術動向と規制の枠組みは？

6.レギュラトリー・アフェアーズの世界市場における主要ベンダーの市場シェアは？

7.レギュラトリー・アフェアーズの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 世界中で創薬と開発が大幅に成長
  - ヘルスケア分野における政府の規制状況の変化
  - 希少疾患の有病率の上昇と新たな感染症の出現
- 抑制要因
  - 規制サービスの提供にかかる高額なコスト
- 機会
  - ヘルスケア機器開発のための主要市場プレーヤー別巨額投資
  - 生物製剤およびジェネリック医薬品に対する消費者の嗜好の高まり
- 課題
  - レギュラトリー・アフェアーズに関連する厳格な政府の政策と規制
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章レギュラトリー・アフェアーズ市場：サービス別

法定代理人
製品登録と臨床試験の申請
規制コンサルティング
規制に関する執筆と出版

第7章レギュラトリー・アフェアーズ市場適応症別

心臓病学
免疫学
神経内科
腫瘍学

第8章レギュラトリー・アフェアーズ市場：ステージ別

臨床研究
前臨床

第9章レギュラトリー・アフェアーズ市場：カテゴリ別

生物製剤
- バイオシミラー
- バイオテクノロジー
薬物
- ジェネリック
- イノベーター
医療機器
- 診断
- 治療学

第10章レギュラトリー・アフェアーズ市場サービスプロバイダー別

社内
外部委託

第11章レギュラトリー・アフェアーズ市場企業規模別

大規模
中規模
小規模

第12章レギュラトリー・アフェアーズ市場：最終用途別

バイオテクノロジー企業
医療機器企業
製薬会社

第13章南北アメリカのレギュラトリー・アフェアーズ市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第14章アジア太平洋地域のレギュラトリー・アフェアーズ市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第15章欧州・中東・アフリカのレギュラトリー・アフェアーズ市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第16章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第17章掲載企業一覧

第18章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. REGULATORY AFFAIRS MARKET RESEARCH PROCESS
FIGURE 2. REGULATORY AFFAIRS MARKET SIZE, 2022 VS 2030
FIGURE 3. REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
FIGURE 5. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 6. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2022 VS 2030 (%)
FIGURE 7. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2022 VS 2030 (%)
FIGURE 8. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2022 VS 2030 (%)
FIGURE 9. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2022 VS 2030 (%)
FIGURE 10. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 11. REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 12. REGULATORY AFFAIRS MARKET DYNAMICS
FIGURE 13. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 24. REGULATORY AFFAIRS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 25. REGULATORY AFFAIRS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. REGULATORY AFFAIRS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 5. REGULATORY AFFAIRS MARKET SIZE, BY LEGAL REPRESENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. REGULATORY AFFAIRS MARKET SIZE, BY PRODUCT REGISTRATION & CLINICAL TRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 10. REGULATORY AFFAIRS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. REGULATORY AFFAIRS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. REGULATORY AFFAIRS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. REGULATORY AFFAIRS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 15. REGULATORY AFFAIRS MARKET SIZE, BY CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. REGULATORY AFFAIRS MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 18. REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 19. REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. REGULATORY AFFAIRS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. REGULATORY AFFAIRS MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 23. REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. REGULATORY AFFAIRS MARKET SIZE, BY GENERICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. REGULATORY AFFAIRS MARKET SIZE, BY INNOVATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 27. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. REGULATORY AFFAIRS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. REGULATORY AFFAIRS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 31. REGULATORY AFFAIRS MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. REGULATORY AFFAIRS MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 34. REGULATORY AFFAIRS MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. REGULATORY AFFAIRS MARKET SIZE, BY MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. REGULATORY AFFAIRS MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. REGULATORY AFFAIRS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. REGULATORY AFFAIRS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 73. CANADA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 75. CANADA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 76. CANADA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 77. CANADA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 78. CANADA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 79. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 80. CANADA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 81. CANADA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 90. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. CHINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. CHINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 127. CHINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 128. CHINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 129. CHINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 130. CHINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 131. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 132. CHINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 133. CHINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. INDIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. INDIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 137. INDIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 138. INDIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 139. INDIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 140. INDIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 141. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 142. INDIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 143. INDIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 154. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 158. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 159. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 160. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 161. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 162. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 163. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 214. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 217. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 218. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 219. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 220. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 221. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 222. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 223. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 245. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 246. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 247. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 249. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 250. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 252. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 253. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 254. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 256. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 257. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 258. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 259. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 260. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 261. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 262. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 263. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 265. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 266. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 267. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 269. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 270. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 271. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 272. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 273. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 274. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 275. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 276. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 277. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 278. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 279. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 280. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 281. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 282. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 283. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 284. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 285. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 286. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 287. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 288. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 289. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 290. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 291. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 292. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 293. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 294. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 305. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 306. ITALY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 307. ITALY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 308. ITALY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 309. ITALY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 310. ITALY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 311. ITALY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 312. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 313. ITALY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 314. ITALY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 315. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 325. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 326. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 327. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 328. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 335. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 336. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 337. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 338. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 339. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 340. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 341. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 342. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 343. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 344. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 345. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 346. POLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 347. POLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 348. POLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 349. POLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 350. POLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 351. POLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 352. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 353. POLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 354. POLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 355. QATAR REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 356. QATAR REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 357. QATAR REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 358. QATAR REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 359. QATAR REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 360. QATAR REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 361. QATAR REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 362. QATAR REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 363. QATAR REGULATORY AFFAIRS MARKET SIZE, BY COMPANY

Product Code: MRR-0D217D5AEA7C

The Global Regulatory Affairs Market is forecasted to grow significantly, with a projected USD 15.63 billion in 2023 at a CAGR of 10.56% and expected to reach a staggering USD 31.71 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Regulatory Affairs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Regulatory Affairs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Services, market is studied across Legal Representation, Product Registration & Clinical Trial Applications, Regulatory Consulting, and Regulatory Writing & Publishing. The Product Registration & Clinical Trial Applications is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Cardiology, Immunology, Neurology, and Oncology. The Neurology is projected to witness significant market share during forecast period.

Based on Stage, market is studied across Clinical Studies and Preclinical. The Preclinical is projected to witness significant market share during forecast period.

Based on Category, market is studied across Biologics, Drugs, and Medical Devices. The Biologics is further studied across Biosimilars and Biotech. The Drugs is further studied across Generics and Innovator. The Medical Devices is further studied across Diagnostics and Therapeutics. The Biologics is projected to witness significant market share during forecast period.

Based on Service Provider, market is studied across In-House and Outsourced. The Outsourced is projected to witness significant market share during forecast period.

Based on Company Size, market is studied across Large, Medium, and Small. The Small is projected to witness significant market share during forecast period.

Based on End-Use, market is studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies. The Medical Device Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Regulatory Affairs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Regulatory Affairs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Regulatory Affairs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Regulatory Affairs Market?

4. What is the competitive strategic window for opportunities in the Global Regulatory Affairs Market?

5. What are the technology trends and regulatory frameworks in the Global Regulatory Affairs Market?

6. What is the market share of the leading vendors in the Global Regulatory Affairs Market?

7. What modes and strategic moves are considered suitable for entering the Global Regulatory Affairs Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Regulatory Affairs Market, by Services, 2022 vs 2030
4.3. Regulatory Affairs Market, by Indication, 2022 vs 2030
4.4. Regulatory Affairs Market, by Stage, 2022 vs 2030
4.5. Regulatory Affairs Market, by Category, 2022 vs 2030
4.6. Regulatory Affairs Market, by Service Provider, 2022 vs 2030
4.7. Regulatory Affairs Market, by Company Size, 2022 vs 2030
4.8. Regulatory Affairs Market, by End-Use, 2022 vs 2030
4.9. Regulatory Affairs Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Significant growth in drug discovery and development worldwide
  - 5.1.1.2. Changing governmental regulatory landscapes for healthcare sector
  - 5.1.1.3. Rising prevalence of rare disorders and emergence of novel infectious diseases
- 5.1.2. Restraints
  - 5.1.2.1. High cost of delivering regulatory services
- 5.1.3. Opportunities
  - 5.1.3.1. Massive investments by the key market players for development of healthcare equipment
  - 5.1.3.2. Increasing consumer preference for biologics and generic drugs
- 5.1.4. Challenges
  - 5.1.4.1. Stringent governmental policies and regulations associated with regulatory affairs
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Regulatory Affairs Market, by Services

6.1. Introduction
6.2. Legal Representation
6.3. Product Registration & Clinical Trial Applications
6.4. Regulatory Consulting
6.5. Regulatory Writing & Publishing

7. Regulatory Affairs Market, by Indication

7.1. Introduction
7.2. Cardiology
7.3. Immunology
7.4. Neurology
7.5. Oncology

8. Regulatory Affairs Market, by Stage

8.1. Introduction
8.2. Clinical Studies
8.3. Preclinical

9. Regulatory Affairs Market, by Category

9.1. Introduction
9.2. Biologics
- 9.2.1. Biosimilars
- 9.2.2. Biotech
9.3. Drugs
- 9.3.1. Generics
- 9.3.2. Innovator
9.4. Medical Devices
- 9.4.1. Diagnostics
- 9.4.2. Therapeutics

10. Regulatory Affairs Market, by Service Provider

10.1. Introduction
10.2. In-House
10.3. Outsourced

11. Regulatory Affairs Market, by Company Size

11.1. Introduction
11.2. Large
11.3. Medium
11.4. Small

12. Regulatory Affairs Market, by End-Use

12.1. Introduction
12.2. Biotechnology Companies
12.3. Medical Device Companies
12.4. Pharmaceutical Companies

13. Americas Regulatory Affairs Market

13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Regulatory Affairs Market

14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Regulatory Affairs Market

15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

レギュラトリー・アフェアーズ市場：サービス別、適応症別、ステージ別、カテゴリー別、サービスプロバイダー別、企業規模別、エンドユーザー別-2023-2030年の世界予測

Regulatory Affairs Market by Services, Indication, Stage, Category, Service Provider, Company Size, End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 レギュラトリー・アフェアーズ市場：サービス別

第7章 レギュラトリー・アフェアーズ市場適応症別

第8章 レギュラトリー・アフェアーズ市場：ステージ別

第9章 レギュラトリー・アフェアーズ市場：カテゴリ別

第10章 レギュラトリー・アフェアーズ市場サービスプロバイダー別

第11章 レギュラトリー・アフェアーズ市場企業規模別

第12章 レギュラトリー・アフェアーズ市場：最終用途別

第13章 南北アメリカのレギュラトリー・アフェアーズ市場

第14章 アジア太平洋地域のレギュラトリー・アフェアーズ市場

第15章 欧州・中東・アフリカのレギュラトリー・アフェアーズ市場

第16章 競合情勢

第17章 掲載企業一覧

第18章 付録